Venoplasty as a key solution for improving dialysis access: a literature review
Main Article Content
Keywords
Venoplasty, Vascular access, Hemodialysis, Venous stenosis, Patency
Abstract
Background: Chronic kidney disease necessitates effective dialysis, which relies heavily on the integrity and patency of vascular access. Venoplasty has emerged as a pivotal intervention for maintaining this access. This literature review aims to evaluate venoplasty as a key solution for improving dialysis access.
Methods: This literature review evaluates the mechanisms, indications, clinical outcomes, and procedural efficacy of venoplasty. A comprehensive literature search was conducted for randomized controlled trials and observational studies from the last decade, focusing on success rates, adverse events, and long-term patency.
Results: Venoplasty, utilizing balloon catheters to dilate stenosed veins, demonstrates a success rate of 70–90% in restoring blood flow. This significantly reduces dialysis-related complications and hospitalizations. However, the risk of re-stenosis persists, often necessitating repeat interventions or alternative strategies like stenting in recurrent cases.
Conclusion: Venoplasty remains a cornerstone for managing central venous obstruction in dialysis patients, significantly improving quality of life and reducing intervention frequency. As chronic kidney disease prevalence rises, integrating venoplasty into standard care is essential. Future research should prioritize advanced techniques, such as drug-coated balloons, to enhance durability and address current limitations in treating vascular access failure.
References
2. Woodrum DA, Bjarnason H, Andrews JC. Portal vein venoplasty and stent placement in the nontransplant population. J Vasc Interv Radiol. 2009;20(5):593-599. doi:10.1016/j.jvir.2009.02.010.
3. Peters CJ, Bode WD, Frankel DS, Garcia F, Supple GE, Giri JS, et al. Percutaneous balloon venoplasty for symptomatic lead-related venous stenosis. Heart Rhythm. 2025;22(8):2082-2091. doi:10.1016/j.hrthm.2024.10.010.
4. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11. doi:10.1016/j.kisu.2021.11.003.
5. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. Published 2021 Mar 29. doi:10.1136/bmj.n71.
6. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5 [Internet]. London: Cochrane; 2024 [Cited 2026 May 19]. [Available from: https://www.cochrane.org/authors/handbooks-and-manuals/handbook].
7. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605. doi:10.1007/s10654-010-9491-z.
8. Khan T, Bhat M, Shah OA, Choh NA, Maqsood S, Shera TA. Percutaneous Transluminal Angioplasty of Dysfunctional Hemodialysis Vascular Access: Can Careful Selection of Patients Improve the Outcomes?. Indian J Nephrol. 2022;32(3):233-239. doi:10.4103/ijn.IJN_113_21.
9. Fatima J, AlGaby A, Bena J, Abbasi MN, Clair DG. Technical considerations, outcomes, and durability of inferior vena cava stenting. J Vasc Surg Venous Lymphat Disord. 2015;3(4):380-388. doi:10.1016/j.jvsv.2015.04.001.
10. Grubb A, Padalia K, Ashur C, Adewumi J, Saqi B, Varela D, et al. Proximal Upper Extremity Access to Facilitate Venoplasty of Lead-Related Venous Occlusions in Patients Undergoing Lead Revision, Device Upgrade, or Reimplantation. Hearth Rhythm. 2024; 21(5):S462-S463. doi:10.1016/j.hrthm.2024.03.1215.
11. Malgor RD, Labropoulos N. Diagnosis of venous disease with duplex ultrasound. Phlebology. 2013;28 Suppl 1:158-161. doi:10.1177/0268355513476653.
12. Bashar K, Conlon PJ, Kheirelseid EA, Aherne T, Walsh SR, Leahy A. Arteriovenous fistula in dialysis patients: Factors implicated in early and late AVF maturation failure. Surgeon. 2016;14(5):294-300. doi:10.1016/j.surge.2016.02.001.
13. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1-S164. doi:10.1053/j.ajkd.2019.12.001.
14. Zhang C, Cai J, Chen Q, Mi X, Li Y. Comparative Efficacy and Safety of Drug-Coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Arteriovenous Access Stenosis in Hemodialysis Patients. Int J Gen Med. 2026;19:569388. doi:10.2147/IJGM.S569388.
15. Trerotola SO. KDOQI Clinical Practice Guideline for Vascular Access 2019 Update: Kinder, Gentler, and More Important Than Ever. J Vasc Interv Radiol. 2020;31(7):1156-1157. doi:10.1016/j.jvir.2020.04.005.
16. Uceda PV, Feldtman RW, Peralta J, Ahn SS. Endovascular treatment of type 3 and 4 thoracic central vein obstruction in hemodialysis patients. J Vasc Surg Venous Lymphat Disord. 2021;9(3):643-651.e3. doi:10.1016/j.jvsv.2020.10.009.
17. Ozyer U, Harman A, Yildirim E, Aytekin C, Karakayali F, Boyvat F. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: a 10-year single-center experience. AJR Am J Roentgenol. 2009;193(6):1672-1679. doi:10.2214/AJR.09.2654.
18. Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M Jr, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603-610. doi:10.1067/mva.2002.122025.
19. Maya ID, O'Neal JC, Young CJ, Barker-Finkel J, Allon M. Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts. Clin J Am Soc Nephrol. 2009;4(1):86-92. doi:10.2215/CJN.02910608.
20. McLafferty RB, Pryor RW 3rd, Johnson CM, Ramsey DE, Hodgson KJ. Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vasc Surg. 2007;45(5):981-985. doi:10.1016/j.jvs.2007.01.013.
21. Andrawos A, Saeed H, Delaney C. A systematic review of venoplasty versus stenting for the treatment of central vein obstruction in ipsilateral hemodialysis access. J Vasc Surg Venous Lymphat Disord. 2021;9(5):1302-1311. doi:10.1016/j.jvsv.2021.02.014.
22. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362(6):494-503. doi:10.1056/NEJMoa0902045.
23. Lok CE, Foley R. Vascular access morbidity and mortality: trends of the last decade. Clin J Am Soc Nephrol. 2013;8(7):1213-1219. doi:10.2215/CJN.01690213.
24. Wu TY, Wu CK, Chen YY, Lin CH. Comparison of Percutaneous Transluminal Angioplasty with Stenting for Treatment of Central Venous Stenosis or Occlusion in Hemodialysis Patients: A Systematic Review and Meta-analysis. Cardiovasc Intervent Radiol. 2020;43(4):525-540. doi:10.1007/s00270-019-02383-7.
25. Kang CH, Yang SB, Lee WH, Ahn JH, Goo DE, Han NJ, et al. Comparison of Open-Cell Stent and Closed-Cell Stent for Treatment of Central Vein Stenosis or Occlusion in Hemodialysis Patients. Iran J Radiol. 2016;13(4):e37994. doi:10.5812/iranjradiol.37994.
26. Bakken AM, Protack CD, Saad WE, Lee DE, Waldman DL, Davies MG. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg. 2007;45(4):776-783. doi:10.1016/j.jvs.2006.12.046.
27. Razavi MK, Rajan DK, Nordhausen CT, Bounsanga J, Holden A. Objective Performance Goals Based on a Systematic Review and Meta-Analysis of Clinical Outcomes for Bare-Metal Stents and Percutaneous Transluminal Angioplasty for Hemodialysis-Related Central Venous Obstruction. J Vasc Interv Radiol. 2023;34(10):1664-1673.e3. doi:10.1016/j.jvir.2023.05.036.
28. Kitrou PM, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E, et al. Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial. J Vasc Interv Radiol. 2017;28(6):811-817. doi:10.1016/j.jvir.2017.03.007
29. Thwaites SE, Robless PA. Central vein stenosis in an Asian hemodialysis population. Asian Cardiovasc Thorac Ann. 2012;20(5):560-565. doi:10.1177/0218492312449634.
30. Kundu S. Review of central venous disease in hemodialysis patients. J Vasc Interv Radiol. 2010;21(7):963-968. doi:10.1016/j.jvir.2010.01.044.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ronald Winardi Kartika, Faculty of Medicine and Health Sciences, Universitas Kristen Krida Wacana, Jakarta, Indonesia ; Education and Training Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Faculty of Medicine and Health Sciences, Universitas Kristen Krida Wacana, Jakarta, Indonesia ;
Education and Training Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Robiyatun, Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Nuly Juariah Mahnulia, Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Vika Wirdhani, Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Iskandar, Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Egi Wigia Kurniahayati, Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Edi Supriadi, Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Hemodialysis Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Sarwoko, Education and Training Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia
Education and Training Unit, Dr. Sitanala General Hospital, Tangerang, Indonesia